89bio, Inc.

NASDAQ:ETNB

9.29 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -142.189-102.026-90.122-49.499-57.42-16.176
Depreciation & Amortization 0.2730.0650.0790.060.0170.006
Deferred Income Tax 0.1270-0.15-0.0690.02-0.02
Stock Based Compensation 16.10610.3568.6783.8070.3890.108
Change In Working Capital 0.65710.5563.252-1.0410.9372.634
Accounts Receivables 000000
Inventory 000000
Accounts Payables -3.9175.6594.7781.131-0.521.509
Other Working Capital 4.5744.897-1.526-2.1721.4571.125
Other Non Cash Items -4.16-0.0411.4820.49830.5970.979
Operating Cash Flow -129.186-81.09-76.781-46.244-25.46-12.469
Investing Activities:
Investments In Property Plant And Equipment -0.004-0.007-0.063-0.126-0.139-0.039
Acquisitions Net 00.034-0.0070.10700
Purchases Of Investments -341.148-152.696-141.2-118.89500
Sales Maturities Of Investments 218.133118.76148.42212.18900
Other Investing Activites -0.123-0.0340.007-0.10700
Investing Cash Flow -123.019-33.9437.159-106.832-0.139-0.039
Financing Activities:
Debt Repayment -2.9630-19.95100-0.1
Common Stock Issued 512.423118.1293.92157.6887.70223.665
Common Stock Repurchased -2.275-0.2980.1440.13400
Dividends Paid 000000
Other Financing Activities -2.275118.1293.920.112023.765
Financing Cash Flow 513.111117.83123.871157.924107.70223.765
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 260.9062.798-45.7514.84882.10311.257
Cash At End Of Period 316.16155.25552.45798.20893.3611.257